Singapore: Australian government has recently made an announcement that parents who refuse to vaccinate their children m...
One of the challenges in the R&D of next generation vaccines is the development of a delivery technology that will b...
When we talk about vaccines, most people think of an injection to prevent childhood infectious disease. However, in rece...
Singapore: Australia-based biotech company, Viralytics, achieved the primary endpoint in its phase II clinical trial of ...
Singapore: Australia's QRxPharma has collaborated with Canadian specialty pharmaceutical company, Paladin Labs on licens...
Hyderabad: With emphasis on cutting-edge innovations this year, BioAsia 2014 under the theme 'Innovate. Evolve.' kick-st...
Singapore: Gilead Sciences' head of commercial operations for the past decade, Mr Kevin Young, who oversaw tremendous sa...
Singapore: Australian Prime Minister Mr Tony Abbott said that the nation is contracting a private company to staff and o...
Singapore: Cardiologists at the University of Rochester Medical Center, US, are launching a new study in an effort to im...
Singapore: The next Viralytics clinical study evaluating multi doses of CAVATAK administered by the intravenous route ...
Singapore: Pharmaxis received a complete response letter from the US FDA confirming that Bronchitol cannot yet be appro...
Singapore: Asia-Pacific, including Japan, China, India, New Zealand, South Korea and Australia, is the fastest growing r...
Singapore: CDC predicts that every year, one in every three adults in the age group of 65 or older falls and around 2 mi...
Industry forecasts by market analysts state that 80 percent of the multinational companies expect to gain a good share i...
Singapore: A recent report released by RnRMarketResearch.com has analyzed the Global Biochips Industry and forecasted th...
Singapore: Australia boasts an advanced healthcare system supported by both the public and private sector involvement. T...
Singapore: Australia-based Patrys, a clinical stage biotechnology company, has been granted orphan drug designation by t...
Singapore: US-Australian drug discovery company, Novogen's drug candidate, Anisina, has progressed successfully in pre-c...
